International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 463-469 doi: 10.5281/zenodo.16786524
Original Article
Karyotyping Study in Primary Amenorrhoea
Published
Aug. 9, 2025
Abstract

Primary amenorrhoea, defined as the absence of menstruation by age 14 without secondary sexual characteristics or by age 16 with them, is a clinical symptom with diverse etiologies. Objective: To determine the frequency and types of chromosomal abnormalities in patients presenting with primary amenorrhoea and to evaluate the clinical significance of cytogenetic analysis in diagnosis and management. Methods: A 25 cases detailed assessment including clinical history, physical examination, hormonal profiling, ultrasonography, and chromosomal analysis was conducted on individuals presenting with primary amenorrhoea, in human genetic lab from B.J. MEDICAL COLLEGE, AHMEDABAD, GUJARAT. Results: Chromosomal abnormalities were identified in a significant proportion of cases, ranging between 15.9% and 63.3%, with Turner’s syndrome, gonadal dysgenesis, and androgen insensitivity syndrome being the most frequently observed. Most anomalies involved numerical or structural abnormalities of the X chromosome. Conclusion: Cytogenetic evaluation is crucial in the diagnostic workup of primary amenorrhoea, aiding in accurate diagnosis, prognosis estimation, and guiding genetic counseling. Incorporating karyotyping into routine assessment enhances clinical decision-making and patient outcomes

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
419 Views
368 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved